Nonsteroidal Topical OK'd for Atopic Dermatitis

Published on 17 Dec 2024 on MedPage Today

Nonsteroidal Topical OK'd for Atopic Dermatitis

The FDA approved tapinarof cream 1% (Vtama) for eczema in individuals ages 2 years and older, drugmaker Organon announced on Monday. Approval of the...

Read the rest of the article

NYSE.OGN price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should...

Organon (OGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is...

Zacks · via Yahoo Finance 20 Dec 2024

FDA expands approval of Vtama to include atopic dermatitis

The cream, an aryl hydrocarbon receptor agonist, was previously approved as a topical, nonsteroid...

McKnight’s Senior Living 19 Dec 2024

Organon's SWOT analysis: stock poised for growth amid challenges By...

Organon (NYSE:OGN), a prominent player in the healthcare sector specializing in women's health an...

Investing.com 18 Dec 2024

Nonsteroidal Topical OK'd for Atopic Dermatitis

The FDA approved tapinarof cream 1% (Vtama) for eczema in individuals ages 2 years and older, dru...

MedPage Today 17 Dec 2024

NJ Life Sciences Forum Reveals Commitment to ‘Advancing Women’s Health’

The HealthCare Institute of New Jersey (HINJ) and Organon hosted the “Advancing Women’s Health”...

New Jersey Business Magazine 17 Dec 2024

FDA approves Organon’s VTAMA cream, 1% for the treatment for AD

Organon (OGN) announced that the U.S. Food and Drug Administration or FDA has approved VTAMA or...

TipRanks · via Yahoo Finance 17 Dec 2024

Nurture Summit Focuses on Better Future for Maternal and Infant Health

First Lady Tammy Murphy held her 7th annual Nurture NJ Leadership Summit in East Brunswick this p...

New Jersey Business Magazine 11 Dec 2024

Newsweek – again – names NJ company America’s Most Responsible

These 21 New Jersey-based firms made the 2025 list. Last year, 18 Garden State businesses landed ...

NJBIZ 10 Dec 2024

Is WisdomTree U.S. SmallCap Dividend ETF (DES) a Strong ETF Right Now?

Representing 30.10% of the portfolio, the fund has heaviest allocation to the Financials sector;...

Zacks · via Yahoo Finance 10 Dec 2024

Untreated Female Infertility Raises Autoimmune Disease Risk

The association between untreated infertility and SARD persisted in analyses restricted to women...

Medscape 9 Dec 2024